The patent cliff is looming and CDMOs need to be prepared, Fujifilm CEO says
As drugmakers prepare for the looming biopharma patent cliff, 2026 has so far been a year for dealmaking. Now, contract manufacturers need to broaden their services to keep up, Fujifilm Biotechnologies CEO Lars Petersen told ...
Lars Petersen, Fujifilm Biotechnologies CEO July 27, 2026 02:30 PM EDT PharmaManufacturing The patent cliff is looming and CDMOs need to be prepared, Fujifilm CEO says Anna Brown News Reporter As drugmakers prepare for the looming biopharma patent cliff, 2026 has so far been a year for dealmaking. Now, contract manufacturers need to broaden their … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that